Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6523 | 1405 | 43.9 | 87% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 5 | Author keyword | 36 | 23% | 10% | 138 |
2 | IL 5 | Author keyword | 20 | 17% | 8% | 110 |
3 | INTERLEUKIN 5 RECEPTOR | Author keyword | 10 | 61% | 1% | 11 |
4 | EOSINOPHIL DIFFERENTIATION FACTOR | Author keyword | 6 | 80% | 0% | 4 |
5 | TRFK 5 | Author keyword | 6 | 80% | 0% | 4 |
6 | LUNG PHARMACOL GRP | Address | 4 | 23% | 1% | 16 |
7 | HUMAN INTERLEUKIN 5 | Author keyword | 4 | 75% | 0% | 3 |
8 | IL 5R | Author keyword | 4 | 75% | 0% | 3 |
9 | IL5RA | Author keyword | 4 | 75% | 0% | 3 |
10 | IMMEDIATE CUTANEOUS HYPERSENSITIVITY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 5 | 36 | 23% | 10% | 138 | Search INTERLEUKIN+5 | Search INTERLEUKIN+5 |
2 | IL 5 | 20 | 17% | 8% | 110 | Search IL+5 | Search IL+5 |
3 | INTERLEUKIN 5 RECEPTOR | 10 | 61% | 1% | 11 | Search INTERLEUKIN+5+RECEPTOR | Search INTERLEUKIN+5+RECEPTOR |
4 | EOSINOPHIL DIFFERENTIATION FACTOR | 6 | 80% | 0% | 4 | Search EOSINOPHIL+DIFFERENTIATION+FACTOR | Search EOSINOPHIL+DIFFERENTIATION+FACTOR |
5 | TRFK 5 | 6 | 80% | 0% | 4 | Search TRFK+5 | Search TRFK+5 |
6 | HUMAN INTERLEUKIN 5 | 4 | 75% | 0% | 3 | Search HUMAN+INTERLEUKIN+5 | Search HUMAN+INTERLEUKIN+5 |
7 | IL 5R | 4 | 75% | 0% | 3 | Search IL+5R | Search IL+5R |
8 | IL5RA | 4 | 75% | 0% | 3 | Search IL5RA | Search IL5RA |
9 | IMMEDIATE CUTANEOUS HYPERSENSITIVITY | 4 | 75% | 0% | 3 | Search IMMEDIATE+CUTANEOUS+HYPERSENSITIVITY | Search IMMEDIATE+CUTANEOUS+HYPERSENSITIVITY |
10 | EOSINOPHILOPOIESIS | 4 | 56% | 0% | 5 | Search EOSINOPHILOPOIESIS | Search EOSINOPHILOPOIESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CIRCULATING EOSINOPHILS | 44 | 77% | 2% | 30 |
2 | CELL REPLACING FACTOR | 42 | 72% | 2% | 33 |
3 | EOSINOPHIL DIFFERENTIATION FACTOR | 39 | 61% | 3% | 41 |
4 | IL 5 RECEPTOR | 31 | 60% | 2% | 34 |
5 | IL 5 | 29 | 23% | 8% | 114 |
6 | NASAL METACHROMATIC CELLS | 25 | 75% | 1% | 18 |
7 | ATOPIC ASTHMA | 23 | 14% | 11% | 150 |
8 | INTERLEUKIN 5 | 22 | 13% | 11% | 161 |
9 | RECOMBINANT HUMAN INTERLEUKIN 5 | 21 | 29% | 4% | 61 |
10 | MURINE INTERLEUKIN 5 | 18 | 89% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
IL-5 and eosinophilia | 2008 | 91 | 60 | 42% |
IL-5-and eosinophil-mediated inflammation: from discovery to therapy | 2009 | 71 | 83 | 43% |
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor | 2012 | 52 | 225 | 25% |
Haemopoietic processes in allergic disease: eosinophil/basophil development | 2009 | 32 | 79 | 70% |
Role of cytokines in allergic airway inflammation | 2007 | 69 | 98 | 29% |
Immunologic basis of antigen-induced airway hyperresponsiveness | 1999 | 723 | 111 | 17% |
Elemental signals regulating eosinophil accumulation in the lung | 2001 | 133 | 35 | 46% |
Interleukin-5 and IL-5 receptor in health and diseases | 2011 | 21 | 113 | 43% |
IL-5-induced airway eosinophilia - the key to asthma? | 2001 | 119 | 103 | 45% |
Immunobiology of Asthma | 2009 | 142 | 101 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUNG PHARMACOL GRP | 4 | 23% | 1.1% | 16 |
2 | U485 | 4 | 29% | 0.9% | 12 |
3 | INFLAMMAT PHARMACOL S | 3 | 38% | 0.4% | 6 |
4 | AJ DREXEL BASIC PL PROT SCI | 3 | 50% | 0.3% | 4 |
5 | FISIOPATOL HUMANA | 3 | 60% | 0.2% | 3 |
6 | CLIN ALLERGY RHEUMATOL | 3 | 10% | 1.8% | 25 |
7 | ASTHMA GRP | 3 | 14% | 1.3% | 18 |
8 | O PEDIAT | 2 | 67% | 0.1% | 2 |
9 | MED PHYS THER Y | 2 | 16% | 0.9% | 12 |
10 | UNITE PHARMACOL CELLULAIRE | 2 | 16% | 0.9% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000219101 | EOSINOPHILS//EOSINOPHIL//TUMOR ASSOCIATED TISSUE EOSINOPHILIA |
2 | 0.0000211959 | EOSINOPHIL CATIONIC PROTEIN//EOSINOPHIL PROTEIN X//LATE ASTHMATIC RESPONSE |
3 | 0.0000137162 | EOTAXIN//CCR3//RANTES |
4 | 0.0000133113 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |
5 | 0.0000119966 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
6 | 0.0000103952 | STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE |
7 | 0.0000097440 | INDUCED SPUTUM//SPUTUM CELL COUNTS//SEVERE ASTHMA |
8 | 0.0000092884 | AIRWAY REMODELING//AIRWAY SMOOTH MUSCLE//AIRWAY REMODELLING |
9 | 0.0000089865 | MOL TUMOR BIOL//CELLULAR GENE THER IES//IL 13 RECEPTOR |
10 | 0.0000088222 | PARASYMPATHETIC NERVES//ALLERGIC GUINEA PIGS//ALUMINIA |